Abstract 14353: Feminizing Hormone Therapy and Subclinical Indicators of CVD Risk in Transgender Women With HIV

Nicholas Fonseca Nogueira; Ana S. Salazar; M A Ruixuan; Natalie Aguilar; Alex Gonzalez; Valeria Porras; Meela Parker; Alejandro Mantero; Barry E. Hurwitz; Maria L. Alcaide; Claudia Martinez

Abstract 14353: Feminizing Hormone Therapy and Subclinical Indicators of CVD Risk in Transgender Women With HIV

Journal article

Peer reviewed

Abstract 14353: Feminizing Hormone Therapy and Subclinical Indicators of CVD Risk in Transgender Women With HIV

Nicholas Fonseca Nogueira, Ana S. Salazar, M A Ruixuan, Natalie Aguilar, Alex Gonzalez, Valeria Porras, Meela Parker, Alejandro Mantero, Barry E. Hurwitz, Maria L. Alcaide, …

Circulation

2021

Abstract

Introduction: Transgender women (TW) are at higher risk of HIV infection compared to cisgender groups and HIV is associated with accelerated cardiovascular disease (CVD) complications. A high propo...

Files and links (2)

url

https://lens.org/061-139-549-616-46XView

url

https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.14353View

Metrics

6 Record Views

Details

Title: Abstract 14353: Feminizing Hormone Therapy and Subclinical Indicators of CVD Risk in Transgender Women With HIV
Creators: Nicholas Fonseca Nogueira
Ana S. Salazar
M A Ruixuan
Natalie Aguilar
Alex Gonzalez
Valeria Porras
Meela Parker
Alejandro Mantero
Barry E. Hurwitz
Maria L. Alcaide
Claudia Martinez
Publication Details: Circulation
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Infectious Diseases; College of A&S; A&S - Psychology
Resource Type: Journal article
Record Identifier: 991031733715302976